A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
Prolyl hydroxylation domain (PHD) enzymes catalyze the hydroxylation of the transcription factor hypoxia‐inducible factor (HIF) and serve as cellular oxygen sensors. HIF and the PHD enzymes regulate numerous potentially tissue‐protective target genes which can adapt cells to metabolic and ischemic s...
Үндсэн зохиолчид: | Mayer, M, Fey, K, Heinze, E, Rainer Wick, C, Abboud, M, Yeh, T, Tumber, A, Orth, N, Schley, G, Buchholz, B, Clark, T, Schofield, C, Willam, C, Burzlaff, N |
---|---|
Формат: | Journal article |
Хэвлэсэн: |
Wiley
2018
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
-н: Andrea Hartner, зэрэг
Хэвлэсэн: (2023-06-01) -
Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
-н: Chan, M, зэрэг
Хэвлэсэн: (2016) -
Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
-н: Yeh, TL, зэрэг
Хэвлэсэн: (2017) -
The use of dioxygen by HIF prolyl hydroxylase (PHD1).
-н: McNeill, L, зэрэг
Хэвлэсэн: (2002) -
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
-н: Mole, D, зэрэг
Хэвлэсэн: (2003)